---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-064413"
form_type: "8-K"
ticker: "ATYR"
cik: "0001339970"
company_name: "aTYR PHARMA INC"
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T11:16:13.303651+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# aTyr Pharma shareholders approve 5M share increase to equity plan; elect two directors

## Summary
- Stockholders approved amendment to 2015 Stock Plan, increasing share reserve by 5,000,000 to 15,719,300 shares.
- Incentive stock option term extended to February 26, 2035.
- Class I directors Paul Schimmel and Sara L. Zaknoen elected with 56.6M and 49.0M votes for, respectively.
- Ratification of Ernst & Young as auditor for FY2025 approved (68.9M for, 175K against).
- Advisory vote on named executive officer compensation approved (55.2M for, 1.35M against).

## SEC filing metadata
- accession: 0000950170-25-064413
- form_type: 8-K
- ticker: ATYR
- cik: 0001339970
- company_name: aTYR PHARMA INC
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339970/000095017025064413/0000950170-25-064413-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339970/000095017025064413/atyr-20240522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-064413
- JSON: https://secwatch.observer/filing/0000950170-25-064413.json
- Plain text: https://secwatch.observer/filing/0000950170-25-064413.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.